Skip to main
NGVT
NGVT logo

Ingevity (NGVT) Stock Forecast & Price Target

Ingevity (NGVT) Analyst Ratings

Based on 2 analyst ratings
Hold
Strong Buy 0%
Buy 50%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Ingevity Corp is positioned for a positive outlook, primarily due to management's strategic asset sales aimed at enhancing the portfolio and reducing operational distractions. This focus on streamlining operations is anticipated to decrease earnings volatility and improve the margin profile across its segments. Furthermore, the company's robust performance in the Performance Chemicals sector, which is vital to its revenue generation, reinforces its financial stability and growth potential.

Bears say

Ingevity Corp's financial outlook appears negative due to a potential second decline in global auto production, which may hinder the company's ability to transition its customer base towards Advanced Functional Additives (AFA), risking a further drop in earnings. Additionally, the earnings projections are under pressure as margins in the 4-5% range could indicate a significant compression of transaction multiples, posing concerns about valuations. Compounding these issues, various risks including potential impacts from patent expirations, automobile tariffs, and competitive market pressures threaten the profitability of Ingevity's Performance Materials segment.

Ingevity (NGVT) has been analyzed by 2 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 50% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Ingevity and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Ingevity (NGVT) Forecast

Analysts have given Ingevity (NGVT) a Hold based on their latest research and market trends.

According to 2 analysts, Ingevity (NGVT) has a Hold consensus rating as of Nov 6, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $58, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $58, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Ingevity (NGVT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.